Publications by authors named "Matthew David Galsky"
Article Synopsis
- The treatment of abiraterone acetate plus prednisone in black men with metastatic castration-resistant prostate cancer (mCRPC) showed similar safety and effectiveness results compared to previous studies predominantly involving white populations.
- Despite the high incidence and mortality rates of prostate cancer in black men, there remains significant underrepresentation of this demographic in clinical trials, hampering efforts to improve treatment outcomes.
- The study was limited by low enrollment (only 11 participants), leading to its premature closure and highlighting the necessity for better recruitment strategies to include more black men in such trials.
